Fundz

Hemab Appoints Anant Murthy as Chief Operating Officer

PUBLIC · COAGSep 02, 2025

Position

Chief Operating Officer

Company

Hemab Therapeutics

Anant Murthy
anant@hemab.com
CopenhagenBiotechnologyHealth CareTherapeutics

Description

Hemab Therapeutics has announced the appointment of Anant Murthy, PhD, as Chief Operating Officer. In this role, Murthy will lead global efforts in market access, launch, and commercialization of innovative treatments for patients with bleeding disorders.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Hemab Therapeutics, and when

A new leader at Hemab Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Hemab Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hemab Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hemab Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hemab Therapeutics

Location

Copenhagen, Capital Region Of Denmark, Denmark

About

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Based in Cambridge, Massachusetts and Copenhagen, Denmark, Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company’s strategic guidance, Hemab 1-2-5, targets the development of 5 clinical assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood clotting disorders like Glanzmann Thrombasthenia, factor VII deficiency, Bernard Soulier Syndrome, Von Willebrand Disease and other serious disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hemab Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Tara
Senior decision-maker at this company
••••••••@••••••••

See Tara's verified email →

Mads
Senior decision-maker at this company
••••••••@••••••••

See Mads's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Hemab Therapeutics's next move

Learn about Strategic plan

Hemab Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.